Summary The blood glucose management algorithm for type 2 diabetes outlines the risks, benefits and costs of available therapies and provides an approach for how to incorporate older and newer
Summary People with type 2 diabetes mellitus (T2DM) have increased risk of dysmetabolic liver disease and liver fibrosis, linked with increased morbidity and mortality. In recent years, non-invasive methods for
With the increasing use of CGM to manage all forms of diabetes the safety of the person using these devices is paramount. The anzCGM Minimum Standards were written by the
Summary Developed by an expert working group of representatives from the Australian Diabetes Society (ADS), Australian Diabetes Educators Association (ADEA), Royal Australian College of General Practitioners (RACGP) and Dietitians Australia,
Summary The National Diabetes Research Strategy (2026–2035) presents a unified national vision to transform Australia’s response to diabetes through a comprehensive forward-looking research and innovation agenda. It is grounded in
Summary A joint guideline by the Australian Diabetes Society (ADS) and Australian and New Zealand Society of Nuclear Medicine (ANZSNM) for PET/CT imaging in patients with type 1 and type
Summary A consensus clinical practice recommendation endorsed by the Australian Diabetes Society (ADS), National Association of Clinical Obesity Services (NACOS), Gastroenterological Society of Australia (GESA) and Australian and New Zealand
Summary Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus Position Statement The use of glycated haemoglobin (HbA1c) for diagnosis of diabetes mellitus has been
Summary The ADS together with ADEA and ANZCA have made an update to the Alert – ‘Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor use in People with Diabetes’ incorporating recently published
ADS Position Statement ‘Medical Certification of Persons with Insulin-treated Diabetes in the Aviation Industry’ This is the first ADS supported position statement to address medical certification of diabetes in
